The 2026 Biotech Divide: When Generative Biology Meets the FDA WallGlobal Report·7 minutes agoINM+11.45%TXG+2.15%
Cathie Wood Scoops Up Tesla Shares as Stock Sinks, Ark Trims Robinhood Amid Crypto Weaknessbenzinga_article·6 hours agoFIG-6.85%IRDM+1.66%
Biotech Stocks At 52-Week Highs - CPHI Soars +790%, XNCR, ETON, TXG, ACHCrttnews·1 day ago, 04:48 AMETON+1.28%CPHI+8.19%
Corporate Restructurings and AI Pivots Dominate Mid-2026 Strategic ShiftsGlobal Report·2 days ago, 04:17 AMCPNG0.00%GEMI-3.51%
The Great Biotech Reckoning: When AI and Gene Editing Meet Wall Street's Patience in 2026Global Report·Jul 19 at 04:13 AMAMGN+1.49%CRSP+0.61%
M&A, AI Drug Discovery, and Late-Stage Clinical Readouts Define US Biotech Q2 TrajectoryGlobal Report·Jul 18 at 04:13 AMAMGN+1.49%CRSP+0.61%
ARK Invest snaps up $16.7M in SPCX shares, trims Deere exposureMSN·Jul 16 at 03:57 AMTWST-1.88%TXG+2.15%
Cathie Wood Bets $16.6 Million on SpaceX as Elon Musk's Rocket Company Falls Below IPO Pricebenzinga_article·Jul 15 at 09:38 PMTXG+2.15%SPCX+2.59%
10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026PR Newswire·Jul 15 at 03:05 PMTXG+2.15%
Top 3 Health Care Stocks That May Implode This Monthbenzinga_article·Jul 15 at 07:56 AMPRVA-1.58%TXG+2.15%
Biotech Stocks At 52-Week Highs - COAG, ALMR, PGNY, TXG, VMDrttnews·Jul 14 at 03:05 AMVMD-2.10%PGNY-2.07%
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $35.46, Implies 17% DownsideTradingView·Jul 13 at 11:20 AMTXG+2.15%
